Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Droxidopa / Pyridostigmine in Orthostatic Hypotension
This study is currently recruiting participants.
Verified January 2013
by Mayo Clinic
Study NCT01370512 Information provided by Mayo Clinic
First Received on June 8, 2011. Last Updated on January 9, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Orthostatic Hypotension
Multiple System Atrophy
Additional conditions recognized in this trial
Atrophy
Hypotension
Hypotension, Orthostatic
Shy-Drager Syndrome
More general conditions related to this trial
Autonomic Nervous System Diseases
Basal Ganglia Diseases
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Orthostatic Intolerance
Pathological Conditions, Anatomical
Primary Dysautonomias
Vascular Diseases
Interventions listed in this trial
Droxidopa
Pyridostigmine Bromide
Additional drug interventions recognized in this trial
Bromides
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Anticonvulsants
Antiparkinson Agents
Central Nervous System Agents
Cholinergic Agents
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
Back to top of Main Content
